Crossref
ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma
AME Clinical Trials Review · 2024
DOI: 10.21037/actr-23-17 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024. Verfasst von Jairo A. Zuluaga und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zuluaga, J. A., Rojas, L., Arrieta, O., & Cardona, A. F. (2024). ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-17
Vancouver
Zuluaga JA, Rojas L, Arrieta O, Cardona AF. ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma. AME Clinical Trials Review. 2024. doi:10.21037/actr-23-17
BibTeX
@article{Zuluaga2024,
author = {Zuluaga, Jairo A. and Rojas, Leonardo and Arrieta, Oscar and Cardona, Andrés F.},
title = {ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma},
journal = {AME Clinical Trials Review},
year = {2024},
doi = {10.21037/actr-23-17}
}
EUVIMED